Heron Therapeutics Inc

The current institutional shareholding score of Heron Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 90.02%, representing a quarter-over-quarter increase of 5.58%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.91% of shares outstanding, with 0.24% increase in holdings.